Abstract: The present invention relates to methods of inhibiting angiogenesis associated with a disease or disorder with peptides homologous to amino acid residues 130-137 or 132-139 of human troponin subunit I.
Type:
Application
Filed:
January 5, 2006
Publication date:
September 21, 2006
Applicants:
Boston Life Sciences, Children's Medical Center Corporation
Inventors:
Richard Thorn, Marc Lanser, Marsha Moses, Dmitri Wiederschain